Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
09/2014
09/25/2014US20140288300 Drug-fluorophore complex for specific detection of tumor cells
09/25/2014US20140288142 Nitric oxide donor compounds
09/25/2014US20140288127 Novel Alkene Oxindole Derivatives
09/25/2014US20140288119 Novel molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
09/25/2014US20140288106 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
09/25/2014US20140288091 Mono-fluoro beta-secretase inhibitors
09/25/2014US20140288068 Alkyl-amine harmine derivatives for promoting bone growth
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2780322A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
09/23/2014US8841463 Cathepsin C inhibitors
09/23/2014US8841453 Hybrid cholinesterase inhibitors
09/23/2014US8841330 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/23/2014US8841324 Heterocyclic compounds as autotaxin inhibitors
09/23/2014US8841320 Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
09/23/2014US8841295 5-lipoxygenase-activating protein (FLAP) inhibitors
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/23/2014US8840878 Peptidomimetic sulfamide compounds and antiviral uses thereof
09/23/2014CA2630046C Fluorescent membrane intercalating probes and methods for their use
09/23/2014CA2628413C Prostaglandins and analogues as agents for lowering intraocular pressure
09/23/2014CA2575853C Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
09/23/2014CA2543199C Use of crth2 antagonist compounds in therapy
09/23/2014CA2500935C Novel compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
09/18/2014WO2014143506A1 Ring opening cross metathesis of vinyl terminated polymers and their functionalized derivatives for fouling mitigation in hydrocarbon refining processes
09/18/2014WO2014142748A1 Quorum sensing inhibitors
09/18/2014WO2014140081A1 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014WO2014139512A1 Derivatives of indoles and carbazoles, method for the production thereof and use thereof as mrsa-sensitive antibiotics
09/18/2014WO2014139388A1 Novel indole derivatives useful as anti-diabetic agents
09/18/2014US20140275569 Method for decarboxylation of amino acids via imine formation
09/18/2014US20140275542 Synthesis of a serotonin reuptake inhibitor
09/18/2014US20140275199 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
09/18/2014US20140275168 Indirubin derivatives, and uses thereof
09/18/2014US20140275155 Substituted bicyclic 1-carboxylic-acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014US20140275108 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/2014US20140275093 Substituted hydroxamic acids and uses thereof
09/18/2014US20140275075 Isatin compounds, compositions and methods for treatment of degenerative diseases and disorders
09/18/2014US20140275048 Prodrugs of fumarates and their use in treating various diseases
09/18/2014US20140275043 Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
09/18/2014US20140275025 Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
09/18/2014DE102008025893B4 Verfahren zur Herstellung von Fettsäureamiden mit gesättigten, ungesättigten oder Hydroxy-Fettsäuren Process for the preparation of fatty acid amides with saturated, unsaturated or hydroxy fatty acids
09/17/2014EP2776393A1 Nampt inhibitors
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835682 Alkaloid aminoester derivatives and medicinal composition thereof
09/16/2014US8835652 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
09/16/2014US8835651 Photoelectric conversion element and dye for photoelectric conversion element
09/16/2014US8835484 Naphthocyanines for use as contrast agents
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835018 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device in which the anthracene derivative is used
09/12/2014WO2014136808A1 Cell-death inhibitor, and production method therefor
09/12/2014WO2014136807A1 Cell-death inhibitor, and novel compound
09/12/2014WO2014135221A1 Polymethine compounds and their use as fluorescent labels
09/11/2014US20140256928 Protecting group for indole group, nucleic acid-synthesizing amidite and nucleic acid-synthesizing method
09/11/2014US20140256782 Opsin-Binding Ligands, Compositions and Methods of Use
09/11/2014US20140256767 Direct inhibitors of keap1-nrf2 interaction as antioxidant inflammation modulators
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256725 Fsh receptor antagonists
09/10/2014EP2774918A1 Novel low-molecule compound for promoting pluripotent stem cell generation, maintenance, and proliferation, and composition and culturing method containing same
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/09/2014US8829204 Modulators of ATP-binding cassette transporters
09/09/2014US8829040 (aza)indole derivative and use thereof for medical purposes
09/09/2014US8829039 Dihydroindolinone derivatives
09/09/2014US8828558 Monoamine compound, charge transport material, composition for charge transport film, organic electroluminescent element, organic EL display, and organic EL lighting
09/09/2014CA2655750C 2-arylindole derivatives as mpges-1 inhibitors
09/04/2014WO2009122433A3 A process for preparation of ramipril
09/04/2014US20140249199 Tak1 kinase inhibitors, compositions, and used related thereto
09/04/2014US20140249197 Novel indole derivatives as selective androgen receptor modulators (sarms)
09/04/2014US20140249148 Selective hdac3 inhibitors
09/03/2014EP2772492A1 Use of an isoxazole derivative for the treatment of withdrawal symptom
09/03/2014EP2772483A1 4-aminocarbazole compound and use of same
09/03/2014EP2771384A1 Polyetherimides, methods of manufacture, and articles formed therefrom
09/03/2014EP2771341A1 Novel compositions and methods for treating cancer
09/03/2014EP2771331A1 Novel process
09/03/2014EP2771321A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
09/03/2014EP2771319A1 Amino acid derivatives functionalized on the n- terminal capable of forming drug incapsulating microspheres
09/03/2014EP2770993A2 Method of treating hcv infection with a small molecule chk2 inhibitor
09/02/2014US8822702 Synthesis of amines and intermediates for the synthesis thereof
09/02/2014US8822690 High transmissional yellow dye for LCD and synthetic method thereof
09/02/2014US8822525 Dimeric IAP inhibitors
09/02/2014US8822524 Substrate-mimetic Akt inhibitor
09/02/2014US8822467 Biaryl oxyacetic acid compounds
09/02/2014US8822414 Heterocyclic compounds suitable for the treatment of dyslipidemia
09/02/2014US8822041 Anthracene derivatives, luminescent materials and organic electroluminescent devices
08/2014
08/28/2014WO2014130834A1 Red fluorescent aldehyde dehydrogenase (aldh) substrate
08/28/2014WO2014129846A1 Organic electroluminescent compounds and an organic electroluminescent device comprising the same
08/28/2014WO2014128549A1 Novel ampk activator
08/28/2014WO2014066613A3 Sphingolipid metabolite mimetics
08/28/2014US20140243324 Use of hematopoietic growth factor mimetics
08/27/2014EP2769974A1 Novel AMPK activator
08/27/2014EP2768808A1 Materials for organic electroluminescent devices
08/27/2014EP2768807A1 Processes for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide and of its precursors
08/27/2014EP2768806A1 Method for preparing silodosin
08/27/2014EP2768805A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
08/27/2014EP2768499A1 Indomethacin analogs for the treatment of castrate-resistant prostate cancer
08/26/2014US8816098 Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative
08/26/2014US8816076 Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
08/26/2014US8815999 Cross-linker
08/26/2014US8815908 Compounds and methods for inhibiting phosphate transport
08/26/2014CA2615666C Novel macrocyclic inhibitors of hepatitis c virus replication
08/21/2014US20140235870 Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereof
08/21/2014US20140235654 Use of derivatives of indoles for the treatment of cancer
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 458